CD48 expression on leukocytes in infectious diseases: Flow cytometric analysis of surface antigen

Pediatrics International

Volumn 40, Issue 6, 1998, Pages 580-585

  Katsuura, Michihiko ^a   Shimizu, Yukitoshi ^a   Akiba, Kaori ^a   Kanazawa, Chikako ^a   Mitsui, Tetsuo ^a   Sendo, Dai ^a   Kawakami, Takako ^a   Hayasaka, Kiyoshi ^a   Yokoyama, Shinkichi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Activation antigen; CD48; Infectious disease

Indexed keywords

CD48 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; APPENDICITIS; ARTICLE; BACTERIAL INFECTION; CHICKENPOX; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFECTION; INFECTIOUS MONONUCLEOSIS; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MEASLES; PRIORITY JOURNAL; RUBELLA; SEPSIS; STREPTOCOCCUS INFECTION; TONSILLITIS; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; FEMALE; FLOW CYTOMETRY; FLUOROIMMUNOASSAY; HUMANS; INFANT; LEUKOCYTES; MALE; STATISTICS, NONPARAMETRIC;

EID: 0032420881     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1998.tb01994.x     Document Type: Article

References (45)

1. Sandrin Ms. Mouhtouns E. Vaughan Ha. Warren Hs, Parish Cr. CD48 is a low affinity ligand for human CD2. J. Immunol. 1993: 151: 4606–13.
2. Arulanandam Ar Moingeon P. Concino Mf et al. A soluble multimetric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: Divergence of CD2 ligands during the evolution of humans and mice. J Exp. Med. 1993; 177: 1439–50.
3. van der Merwe Pa. Barclay An, Mason Dw et al. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 1994; 33: 10 149–60.
4. Gollob Ja, Li J., Kawasaki H. et al. Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-2. J. Immunol. 1996:157: 1886–93.
5. Klyushnenkova En, Li L., Armitage Rj, Choi Ys. CD48 delivers an accessory signal for CD40-mediated activation of human B cells. Cell. Immunol. 1996; 174: 90–8.
6. Thorley-Lawson Da, Schooley Rt, Bhan Ak, Nadler Lm. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lympho-blasts. Cell 1982; 30: 415–25.
7. Yokoyama S., Staunton D., Fisher R., Amiot M., Fortin Jj, Thorley-Lawson Da. Expression of the Blast-1 activation/ adhesion molecule and its identification as CD48. J. Immunol. 1991;146: 2192–200.
8. Klickstein Lb, Springer Ta. Adhesion structure subpanel 1, E rosetting/GPI anchor: CD2, CD48, CD55, CD58, CD59, CD99 and CDw 108. In: Shlossman Sf, Boumsell L., Gilks W. et al, eds. Leukocyte Typing V. Oxford University Press, New York, 1995; 1468–73.
9. Katsuura M., Yokoyama S., Shimizu Y. et al. Increased expression of CD48 on neutrophils activated in childhood patients with aplastic anemia. Int. J. Hematol. 1994; 60: 281–5.
10. De Waele M., Thielemans C., Van Camp Bkg. Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies. N. Engl. J. Med. 1981:304: 460–2.
11. Arvin Am, Koropchak Cm, Williams Brg, Grumet Fc, Foung Kh. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J. Infect. Dis. 1986; 154: 422–9.
12. Guyre Pm, Campbell As, Kniffin Wd, Fanger Mw. Monocytes and polymorphonuclear neutrophils of patients with streptococcal pharyngitis express increased numbers of type I IgG receptors. J. Clin. Invest. 1990; 86: 1892–6.
13. Gadd S. Cluster report: CD14. In: Knapp W., DÖRken B., Gills Wr et al, eds. Leucocyte Typing III. Oxford University Press, Oxford, 1989; 787–9.
14. Liles Wc, Van Voorhis Wc. Nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J. Infect. Dis. 1995; 172: 1573–80.
15. Maloney Em, Pate E., Wiktor Sz et al. The relative distribution of T cell subsets is altered in Jamaican children infected with human T cell lymphotropic virus type I. J. Infect. Dis. 1995; 172: 867–70.
16. Cossarizza A., Ortolani C., Mussini C. et al. Massive activation of immune cells with intact T cell repertoire in acute human immunodeficiency virus syndrome. J. Infect. Dis. 1995; 172: 105–12.
17. Noah Tl, Becker S. Respiratory syncytial virus-induced cytokine production by human bronchial epithelial cell line. Am. J. Physiol. 1993; 265: L472–8.
18. Subauste Mc, Jacoby Db, Richards Sm, Proud D. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J. Clin. Invest. 1995; 96: 549–57.
19. Lynn Wa, Golenbock Dt. Lipopolysaccharide antagonists. Immunol. Today 1992; 13: 271–6.
20. Berger M., Wetzler Em, Wallis Rs. Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils. Blood 1988; 71: 151–8.
21. Sasahara K., Tobe T., Tomita M. et al. Selective expression of monocyte chemotactic and activating factor/monocyte chemo-attractant protein 1 in human blood monocytes by Mycobacterium tuberculosis. J. Infect. Dis. 1994; 170: 1238–47.
22. Jupin C., Anderson S., Damais C., Alouf Je, Parant M. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factor and y interferon. J. Exp. Med. 1998; 167: 752–61.
23. Parsonnet J., Hickman Rk, Eardley Dd, Pier Gb. Induction of human interleukin-1 by toxic-shock-syndrome Toxin 1. 1985; 151: 514–22.
24. Anderson Lj, Tsou C., Potter C. et al. Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J. Infect. Dis. 1994; 170: 1201–8.
25. Pelloux H., Pernod G., Ricard J. et al. Interleukin-6 is secreted by human monocytes after stimulation with anti-Toxoplasma gondi sera. J. Infect. Dis. 1994; 169: 1181–2.
26. Lahesma R., Soderberg C., Bliska J. et al. Pathogen antigen- and superantigen-reactive synovial fluid T cells in reactive arthritis. J. Infect. Dis. 1995; 172: 1290–7.
27. Proud D., Gwaltney Jr Jm, Hendley Jo, Dinarello Ca, Gillis S., Schleimer Rp. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhino-virus colds. J. Infect. Dis. 1994; 169: 1007–13.
28. Takamiya H., Maehara N., Nakayama T. et al. Production of circulation interferon in children with varicella. Arch. Virol. 1990; 112: 229–33.
29. Ohga S., Miyazaki C., Okada K., Akazawa K., Ueda K. The inflammatory cytokines in measles: correlation between serum interferon-y levels and lymphocyte subpopulations. Eur. J. Pediatr. 1992; 151: 492–6.
30. Choi Am, Jacoby D. Influenza virus A infection induces interleukin-8 gene expression in human airway epithelial cells. FEBS Lett. 1992; 309: 327–9.
31. Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J. 1990; 4: 2860–7.
32. Baggiolini M., Walz A., Kunkel Sl. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 1989; 84: 1045–9.
33. Klebanoff Sj, Vadas Ma, Harlan Jm et al. Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 1986; 136: 4220–5.
34. Yuo A., Kitagawa S., Ohsaka A. et al. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: Potentiation of responses triggered by receptor- mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 1989; 74: 2144–9.
35. Perussia B., Kobayashi M., Rossi Me, Anegon I., Trinchieri G. Immune interferon enhances functional properties of human granulocytes: Role of Fc receptors and effect of lymphotoxin, tumor necrosis factor and granulocyte-macrophage colony-stimulating factor. J Immunol. 1987; 138: 765–74.
36. Buckle Am, Jayaram Y., Hogg N. Colony-stimulating factors and interferon-gamma differentially effect cell surface molecules shared by monocytes and neutrophils. Clin. Exp. Immunol. 1990; 81: 339–45.
37. Buckle A-M, Hogg N. The effect of IFN-γ and colony-stimulating factors on the expression of neutrophil cell membrane receptors. J. Immunol. 1989; 143: 2295–301.
38. Repp R., Valerius T., Sendler A. et al. Neutrophils express the high affinity receptor for IgG (Feγ RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood 1991; 78: 885–9.
39. Jayaram Y., Buckle Am, Hogg N. The Fc receptor, FcRI, and other activation molecules on human mononuclear phagocytes after treatment with interferon-gamma. Clin. Exp. Immunol. 1988; 75: 414–20.
40. Basham Ty, Merigan Tc. Recombinant interferon-y increases HLA-DR synthesis and expression. J. Immunol. 1983; 130: 1492–4.
41. Marchant A., Duchow J., Delville Jp, Goldman M. Lipopolysaccharide induces up-regulation of CD 14 molecule on monocytes in human whole blood. Eur. J. Immunol. 1992; 22: 1663–5.
42. Lin Ry, Astiz Me, Saxon Jc, Rackow Ec. Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14 and IL-2R expression. Chest 1993; 104: 847–53.
43. Kimura S., Inoue T., Yamashita T., Midorikawa Y., Arai S., Sendo F. Production of factor(s) that render polymorphonuclear leukocytes cytostatic from spleen cells stimulated with a streptococcal preparation, OK-432. Cancer Res. 1987; 47: 6204–9.
44. Matsubara S., Suzuki F., Ishida N. Induction of immune interferon in mice treated with bacterial immunopotentiator, OK-432. Cancer Immunol. Immunother. 1979; 6: 41–6.
45. Tissot C., Rebouissou C., Klein B., Mechti N. Both human αβ and γ interferons upregulate the expression of CD48 cell surface molecules./ Interferon Cytokine Res. 1997; 17: 17–26.